Literature DB >> 2870283

Haemodialysis versus CAPD: equal predisposition to amyloidosis?

F W Ballardie, D N Kerr, G Tennent, M B Pepys.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2870283     DOI： 10.1016/s0140-6736(86)91799-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 2.  Dialysis arthropathy, amyloidosis and beta-2 microglobulin.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

3.  Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis.

Authors:  J M Theaker; A E Raine; A J Rainey; A Heryet; A Clark; D O Oliver
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

4.  Synovial amyloid in chronic haemodialysis contains beta 2 microglobulin.

Authors:  F E Bruckner; M Burke; R S Pereira; A J Eisinger; M Bending; J Kwan; A K Osman; B Watson
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.